ASX:SHL

4 stories mentioning ASX:SHLUpdated 42d ago

Every FINWIRES story that references ASX:SHL, newest first.

Sonic Healthcare's Fiscal 2026 EBITDA Forecast to Be AU$1.9 Billion, Jefferies Says

Sonic Healthcare (ASX:SHL) continues to expect earnings before interest, taxes, depreciation, and amortization (EBITDA) for fiscal year 2026 in the range of AU$1.87 billion to AU$1.95 billion at constant currency, compared with Jefferies' forecast of AU$1.9 billion, according to a Thursday note from Jefferies.Sonic completed its previously flagged sale and leaseback of its Brisbane Hub Laboratory, and further property sale and leaseback transactions are under consideration.The purchase price was AU$445 million, with rent, under a triple net lease arrangement, to begin at AU$25 million per annum. Sonic expects to book a fiscal year 2026 gain on sale before tax of around AU$100 million.The investment firm retained its hold rating on Sonic and raised the price target to AU$22.60 per share from AU$22.55 per share.

ASX:SHL

Asia44d ago

Jarden Research Adjusts Sonic Healthcare's Price Target to AU$22.30 from AU$21.90, Keeps at Neutral

Sonic Healthcare (ASX:SHL) has an average rating of hold and mean price target of AU$22.89, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

ASX:SHL

Asia45d ago

Sonic Healthcare Sale-And-Leaseback Boosts Liquidity, But Earnings Headwinds Persist, Jarden Says

Sonic Healthcare (ASX:SHL) completed its Bowen Hills laboratory sale-and-leaseback, improving liquidity and supporting capital management initiatives, though earnings and reimbursement pressures continue to weigh on the outlook, Jarden said in a Monday note.The company has completed the sale and leaseback for AU$445 million, in line with expectations, with the property now subject to a 20-year triple-net lease generating around AU$25 million in annual rent and Consumer Price Index-linked increases capped at around 3.5% per annum.The company expects a one-off pre-tax gain of about AU$100 million and will apply accumulated capital losses of roughly AU$170 million to reduce the tax liability on the transaction to around AU$40 million.Jarden said the transaction supports the company's capital management strategy and is expected to improve near-term liquidity, with proceeds broadly in line with guidance and helping to ease cash flow pressure from elevated capital expenditure, tax instalments, dividends, and potential Change Healthcare-related repayments.The advisory firm added that net debt-to-earnings before interest, taxes, depreciation, and amortization rose to 2.5 times in the first half from 2.1 times following recent acquisitions, with the cash injection expected to support gradual share buybacks alongside potential further asset sales.Jarden cut fiscal year 2027 and fiscal year 2028 diluted earnings by 1.7% and 1.4% on higher depreciation and net interest expense from the transaction structure.Jarden maintained its neutral rating on Sonic Healthcare and increased its price target to AU$22.30 from AU$21.90.

ASX:SHL

Asia45d ago

Charter Hall Social Infrastructure REIT Acquires AU$53 Million Stake in Sonic-Leased Brisbane Pathology Hub

Charter Hall Social Infrastructure REIT (ASX:CQE) acquired a 25% interest in a central pathology laboratory in Brisbane fully leased to Sonic Healthcare (ASX:SHL) for AU$53 million, according to an Australian bourse filing on Monday after market hours.The property, secured by a 20-year triple-net lease with extended options, was acquired from Sonic via a sale-and-leaseback transaction alongside Charter Hall Group's (ASX:CHC) newly established Charter Hall Inflation Protected Partnership 1, per the filing.The company will fund its investment through ongoing early learning asset curation, having contracted the sale of nine assets since Dec. 31, 2025, for AU$37.1 million at a 4.6% yield and a 3.4% premium to book value, the filing said.The company reaffirmed its fiscal 2026 earnings guidance of at least AU$0.172 per unit and distribution guidance of AU$0.17 per unit, the filing added.

ASX:CHCASX:CQEASX:SHL

Track with the FINWIRES app suite

FolioX

Track ASX:SHL in your portfolio

WheelAI

Analyze ASX:SHL options with the wheel strategy

StockInsider

See market sentiment on ASX:SHL